249 filings
Page 5 of 13
8-K
lwd7nsk
14 Nov 17
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
12:00am
8-K
88zi429 dcdlzm
14 Nov 17
Molecular Templates Strengthens Management Team with Appointment of
12:00am
8-K
ah1 6ren5g3k
25 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K/A
uzyrd
17 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
dapujpcc2
13 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
pz4 96o3s6mia3
7 Aug 17
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements
12:00am
8-K
ks7ib xfs
1 Aug 17
Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
12:00am
8-K
8plimhn
20 Jul 17
Other Events
12:00am
8-K
rfgs9nt2d7 c8f
22 Jun 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K
l8o2z
2 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
mpzr7 t5q
15 May 17
Threshold Pharmaceuticals Reports First Quarter Financial Results
12:00am
8-K
t35x8
30 Mar 17
Regulation FD Disclosure
12:00am
8-K
2xdw a5e13lyyu7gmj
29 Mar 17
Regulation FD Disclosure
12:00am
8-K
2s4fmj07p6o96aw
27 Mar 17
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
ggbawa2 7omxt64
17 Mar 17
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
12:00am
8-K
v4ytxfktwqkp
15 Nov 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
7x1xk85
7 Nov 16
Threshold Pharmaceuticals Reports Third Quarter Financial Results
12:00am
8-K
374nn7hwr8w30j
18 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
1fi0z
30 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
if6rkwr0os5ma7i3f0
29 Sep 16
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
12:00am